Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 6/2006

01-11-2006

An update on autonomic neuropathy affecting the gastrointestinal tract

Authors: Liza K. Phillips, MBBS, Christopher K. Rayner, MBBS, PhD, FRACP, Karen L. Jones, Dip App Sci, PhD, Michael Horowitz, MBBS, PhD, FRACP

Published in: Current Diabetes Reports | Issue 6/2006

Login to get access
Metadata
Title
An update on autonomic neuropathy affecting the gastrointestinal tract
Authors
Liza K. Phillips, MBBS
Christopher K. Rayner, MBBS, PhD, FRACP
Karen L. Jones, Dip App Sci, PhD
Michael Horowitz, MBBS, PhD, FRACP
Publication date
01-11-2006
Publisher
Current Medicine Group
Published in
Current Diabetes Reports / Issue 6/2006
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-006-0073-0

Other articles of this Issue 6/2006

Current Diabetes Reports 6/2006 Go to the issue

OriginalPaper

Negative pressure wound therapy: Evidence-based treatment for complex diabetic foot wounds

OriginalPaper

Diabetic Nephropathy: Worldwide epidemic and effects of current treatment on natural history

Invited Commentary

An appraisal of aspirin therapy in diabetes

News

Web alert

OriginalPaper

The diabetic foot: The importance of biofilms and wound bed preparation

OriginalPaper

Transplantation for type 1 diabetes: Whole organ pancreas and islet cells
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits